hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
Sunday 14 July 2013
BioCryst nearly ready to submit new influenza drug to FDA - Vaccine News Daily
BioCryst nearly ready to submit new influenza drug to FDA - Vaccine News Daily
INFLUENZA - GOOGLE NEWS | 13 JULY 2013
http://pulse.me/s/o3abi
BioCryst nearly ready to submit new influenza drug to FDAVaccine News DailyBioCryst Pharmaceuticals, Inc., announced on ... Read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment